Overview of Triazolam
Triazolam, with the National Drug Code (NDC) 50742-0645, is a benzodiazepine used primarily for the short-term treatment of insomnia. It is manufactured by Ingenus Pharmaceuticals, LLC[5].
Market Context
Benzodiazepine Market
The benzodiazepine market, while not as rapidly growing as some other pharmaceutical segments, remains stable due to the ongoing demand for treatments of anxiety, insomnia, and other related conditions. However, this market is also subject to stringent regulatory oversight and public health concerns regarding addiction and misuse.
Regulatory Environment
FDA Oversight and NDC Directory
The FDA's National Drug Code (NDC) Directory plays a crucial role in regulating and tracking drug products, including those manufactured by Ingenus Pharmaceuticals. The NDC Directory contains detailed information about finished drug products, including prescription and over-the-counter drugs, approved and unapproved drugs, and repackaged and relabeled drugs[1].
Reporting Requirements
Manufacturers like Ingenus Pharmaceuticals must provide the FDA with a current list of all drugs manufactured, prepared, propagated, compounded, or processed in commercial distribution in the U.S. This includes periodic reports that help the FDA monitor the market and ensure compliance with regulatory requirements[1].
Pricing Dynamics
Current Pricing
As of the latest available data, the pricing for Triazolam (NDC 50742-0645) is not explicitly listed in public reports. However, pricing for benzodiazepines can vary based on factors such as dosage, formulation, and market competition.
Price Trends in Pharmaceuticals
The pharmaceutical market is subject to various factors that influence pricing, including regulatory changes, patent expirations, and the introduction of generic alternatives. For example, the NSCLC market has seen significant price increases driven by premium-priced immunotherapies and targeted therapies, but also faces challenges from patent expirations and the rise of generics[4].
Price Projections
Generic Competition
Triazolam, being a well-established drug, is likely to face competition from generic versions. Generic competition typically leads to a decrease in prices as multiple manufacturers enter the market. For instance, the sales of generic versions of drugs like erlotinib and pemetrexed have significantly impacted the market prices of their branded counterparts[4].
Market Demand and Supply
The demand for benzodiazepines, including Triazolam, is relatively stable but can be influenced by public health initiatives and changes in prescribing practices. Supply chain disruptions or changes in manufacturing costs can also impact pricing.
Predictions for 2025
Regulatory and Market Trends
In 2025, the biopharma and biotech industries are expected to see significant changes, including accelerated clinical trial designs and evolving regulatory frameworks. While these trends are more relevant to innovative therapies, they can indirectly influence the broader pharmaceutical market, including generics and established drugs like Triazolam[3].
Economic Factors
Economic factors such as inflation, healthcare policy changes, and global economic conditions can also influence drug pricing. For example, the biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029, driven by technological advancements and shifting regulatory landscapes[3].
Key Takeaways
- Regulatory Compliance: Manufacturers must adhere to FDA reporting requirements and regulatory oversight.
- Generic Competition: The presence of generic alternatives is likely to impact the pricing of Triazolam.
- Market Demand: Stable but subject to changes in public health policies and prescribing practices.
- Economic Factors: Inflation, healthcare policies, and global economic conditions can influence pricing.
FAQs
What is the primary use of Triazolam?
Triazolam is primarily used for the short-term treatment of insomnia.
Who manufactures Triazolam with the NDC 50742-0645?
Ingenus Pharmaceuticals, LLC manufactures Triazolam with the NDC 50742-0645.
How does the FDA regulate drug products like Triazolam?
The FDA regulates drug products through the National Drug Code (NDC) Directory, which contains detailed information about finished drug products, including reporting requirements for manufacturers.
What factors influence the pricing of Triazolam?
Pricing is influenced by factors such as generic competition, market demand, supply chain conditions, and broader economic factors.
Are there any significant market trends expected in 2025 that could impact Triazolam pricing?
While specific trends for benzodiazepines are not highlighted, broader pharmaceutical market trends such as regulatory changes and economic factors could indirectly influence pricing.
Sources
- FDA's National Drug Code Directory - FDA
- Drug Price Increases Report - New York State Department of Financial Services
- 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
- NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
- Ingenus Pharmaceuticals, LLC - List of Drugs - Find-A-Code
